T helper 17 cells and B cells can work in concert to spark long-lasting protection against solid tumors, a research team at Winship Cancer Institute of Emory University found.
Jill S. Barnholtz-Sloan was appointed chief administrative officer and associate director for research administration at Winship Cancer Institute of Emory University, effective July 21.
Breast medical oncologist and cancer survivorship expert Neil M. Iyengar was appointed director of survivorship services at Winship Cancer Institute of Emory University.
Breast cancer surgeon Tari A. King was appointed as chief surgical officer for the cancer service line at Winship Cancer Institute of Emory University and Emory Healthcare. Joining Emory on July 14, she will also be the chief of the newly formed Division of Breast Surgery in the Department of Surgery at Emory University School of Medicine and co-director of Winship’s Glenn Family Breast Center.
Leon Bernal-Mizrachi was appointed the inaugural chair of the Department of Cancer Medicine in the Wake Forest University School of Medicine at Atrium Health Wake Forest Baptist, effective April 1.
Treatment with an indefinite course of osimertinib dramatically improves progression-free survival for patients with stage 3 non-small cell cancer, according to the results of the LAURA trial. The median PFS was 39.1 months in the osimertinib group, compared to 5.6 months with the placebo group.
As architects, we welcomed the challenge set forth by Emory Healthcare and the Emory Woodruff Health Sciences Center to build a new cancer care center for Winship Cancer Institute of Emory University.
Walter J. Curran Jr., former executive director of Winship Cancer Institute of Emory University, was named chief of Piedmont Oncology Institute (Piedmont Oncology), effective Jan. 9.
Winship Cancer Institute of Emory University received a three-year, $24.8 million cooperative agreement from the Advanced Research Projects Agency for Health to lead the CUREIT program: “Curing the Uncurable via RNA-Encoded Immunogene Tuning.”
Suresh Ramalingam, executive director of Winship Cancer Institute of Emory University, was awarded the Paul A. Bunn, Jr. Scientific Award Sept. 9 at the 2023 IASLC World Conference on Lung Cancer.
